Annals of Occupational Hygiene Advance Access originally published online on March 2, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann. occup. Hyg., Vol. 48, No. 3, pp. 237-244, 2004
© 2004 British Occupational Hygiene Society
Published by Oxford University Press
Occupational Dermal Exposure to Cyclophosphamide in Dutch Hospitals: A Pilot Study
1 Environmental and Occupational Health Group, Institute for Risk Assessment Sciences, Utrecht University, PO Box 80176, 3508 TD Utrecht, The Netherlands; 2 National Cancer Institute, Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, Rockville, MD, USA
Received 2 June 2003; in final form 27 October 2003; published online on 2 March 2004
Introduction: Several studies have shown that exposure to antineoplastic drugs can cause reproductive toxic effects as well as carcinogenic effects. Presence of these drugs in the urine of hospital personnel has been widely studied and some work has been done on exposure by inhalation. So far, assessment of dermal exposure to antineoplastic drugs has not been extensively studied. In this pilot study we assessed potential and actual dermal exposure for several common hospital tasks. Results were used to derive an optimal measurement strategy for a currently ongoing exposure survey. Methods: Dermal exposure to cyclophosphamide was determined in three Dutch hospitals during five tasks (preparation, decanting urine, washing the patient, removing bed sheets and cleaning the toilet) using pad samples on 10 body locations. In addition, protective medical gloves (worn during the performance of these activities) were collected to estimate potential exposure of the hands. Subsequently, hands were washed to measure actual exposure of the hands. Bulk samples (i.e. application and body fluids) were collected and possible contact surfaces were monitored to assess the amount of cyclophosphamide potentially available for exposure. Results: The results show that hospital personnel (i.e. pharmacy technicians and oncology nurses) are dermally exposed to cyclophosphamide during performance of their daily duties. Exposure occurred predominantly on the hands and sporadically on other body locations (i.e. forehead and forearms). Gloves used during preparation of cyclophosphamide were more contaminated than gloves used in other tasks, however, actual exposure of the hands (underneath the gloves) was highest during decanting of urine of treated patients. Glove samples correlated significantly with handwash samples (r = 0.57, P = 0.03, n = 15). The level of protection from gloves varied between tasks, being highest for gloves used during preparation (median = 98%) and lowest for gloves used during decanting urine (median = 19%). Conclusion: This pilot study demonstrated that dermal exposure to cyclophosphamide is common among hospital personnel. The results showed that hands, forearms and forehead accounted for 87% of the cyclophosphamide total body exposure. Glove samples together with handwash samples enabled estimation of glove efficiency, which appeared to vary strongly between tasks observed.
Keywords: antineoplastic drugs; cleaning personnel; cyclophosphamide; dermal exposure; hospital; nurses; pharmacy technicians
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. FRANSMAN, S. PEELEN, S. HILHORST, N. ROELEVELD, D. Heederik, and H. KROMHOUT A Pooled Analysis to Study Trends in Exposure to Antineoplastic Drugs Among Nurses Ann. Hyg., April 1, 2007; 51(3): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Meijster, W Fransman, J van Hemmen, H Kromhout, D Heederik, and E Tielemans A probabilistic assessment of the impact of interventions on oncology nurses' exposure to antineoplastic agents Occup. Environ. Med., August 1, 2006; 63(8): 530 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. MARQUART, N. D. WARREN, J. LAITINEN, and J. J. VAN HEMMEN Default Values for Assessment of Potential Dermal Exposure of the Hands to Industrial Chemicals in the Scope of Regulatory Risk Assessments Ann. Hyg., July 1, 2006; 50(5): 469 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. WARREN, H. MARQUART, Y. CHRISTOPHER, J. LAITINEN, and J. J. VAN HEMMEN Task-based Dermal Exposure Models for Regulatory Risk Assessment Ann. Hyg., July 1, 2006; 50(5): 491 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. MASON, S. BLAIR, C. SAMS, K. JONES, S. J. GARFITT, M. J. CUSCHIERI, and P. J. BAXTER Exposure to Antineoplastic Drugs in Two UK Hospital Pharmacy Units Ann. Hyg., October 1, 2005; 49(7): 603 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. CRAUSTE-MANCIET, P. J. M. SESSINK, S. FERRARI, J.-Y. JOMIER, and D. BROSSARD Environmental Contamination with Cytotoxic Drugs in Healthcare Using Positive Air Pressure Isolators Ann. Hyg., October 1, 2005; 49(7): 619 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B van Wendel de Joode, R Vermeulen, J J van Hemmen, W Fransman, and H Kromhout Accuracy of a semiquantitative method for Dermal Exposure Assessment (DREAM) Occup. Environ. Med., September 1, 2005; 62(9): 623 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Connor, P. J. M. Sessink, B. R. Harrison, J. R. Pretty, B. G. Peters, R. M. Alfaro, A. Bilos, G. Beckmann, M. R. Bing, L. M. Anderson, et al. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: Results of three studies Am. J. Health Syst. Pharm., March 1, 2005; 62(5): 475 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. RAJAN-SITHAMPARANADARAJAH, M. ROFF, P. DELGADO, K. ERIKSSON, W. FRANSMAN, J. H. J. GIJSBERS, G. HUGHSON, M. MAKINEN, and J. J. VAN HEMMEN Patterns of Dermal Exposure to Hazardous Substances in European Union Workplaces Ann. Hyg., April 1, 2004; 48(3): 285 - 297. [Abstract] [Full Text] [PDF]
|
|